BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30465782)

  • 21. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
    Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two validated liquid chromatography-mass spectrometry methods with different pretreatments for the quantification of an anti-CD47 monoclonal antibody in rat and cynomolgus monkey serum compared with an electrochemiluminescence method.
    Gao Y; Zhang D; Yang C; Duan X; Li X; Zhong D
    J Pharm Biomed Anal; 2019 Oct; 175():112792. PubMed ID: 31377653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
    Jakes C; Millán-Martín S; Carillo S; Scheffler K; Zaborowska I; Bones J
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1998-2012. PubMed ID: 33513021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Discovery and Quantitation of Protein Heterogeneity via LC-MS/MS Peptide Mapping for Clone Selection of a Therapeutic Protein.
    Traylor MJ; Tchoudakova AV; Lundquist AM; Gill JE; Boldog FL; Tangarone BS
    Anal Chem; 2016 Sep; 88(18):9309-17. PubMed ID: 27569415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
    Zhang Z; Yan Y; Wang S; Li N
    MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.
    Kuang J; Tao Y; Song Y; Chemmalil L; Mussa N; Ding J; Li ZJ
    Anal Bioanal Chem; 2021 Mar; 413(8):2113-2123. PubMed ID: 33543314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated middle-up approach for the characterization of biotherapeutic products by combining on-line hinge-specific digestion with RPLC-HRMS analysis.
    Camperi J; Guillarme D; Lei M; Stella C
    J Pharm Biomed Anal; 2020 Apr; 182():113130. PubMed ID: 32004773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiattribute Monitoring of Aggregates and Charge Variants of Monoclonal Antibody through Native 2D-SEC-MS-WCX-MS.
    Kumar S; Savane TS; Rathore AS
    J Am Soc Mass Spectrom; 2023 Jul; 34(7):1263-1271. PubMed ID: 37327380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a biotherapeutic immunoaffinity-LC-MS/MS assay in monkey serum: 'plug-and-play' across seven molecules.
    Kaur S; Liu L; Cortes DF; Shao J; Jenkins R; Mylott WR; Xu K
    Bioanalysis; 2016 Aug; 8(15):1565-1577. PubMed ID: 27396481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a rapid RP-UHPLC-MS method for analysis of modifications in therapeutic monoclonal antibodies.
    Zhang B; Jeong J; Burgess B; Jazayri M; Tang Y; Taylor Zhang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():172-181. PubMed ID: 27233581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies.
    Furlong MT; Ouyang Z; Wu S; Tamura J; Olah T; Tymiak A; Jemal M
    Biomed Chromatogr; 2012 Aug; 26(8):1024-32. PubMed ID: 22623136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Resolution Ion-Mobility-Enabled Peptide Mapping for High-Throughput Critical Quality Attribute Monitoring.
    Arndt JR; Wormwood Moser KL; Van Aken G; Doyle RM; Talamantes T; DeBord D; Maxon L; Stafford G; Fjeldsted J; Miller B; Sherman M
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2019-2032. PubMed ID: 33835810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fully Unattended Online Protein Digestion and LC-MS Peptide Mapping.
    Richardson J; Zhang Z
    Anal Chem; 2023 Oct; 95(42):15514-15521. PubMed ID: 37816151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotyping and Semi-Quantitation of Monkey Anti-Drug Antibodies by Immunocapture Liquid Chromatography-Mass Spectrometry.
    Huang X; Xu X; Partridge MA; Chen J; Koehler-Stec E; Sumner G; Qiu H; Torri A; Li N
    AAPS J; 2021 Jan; 23(1):16. PubMed ID: 33404777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative and quantitative characterization of protein biotherapeutics with liquid chromatography mass spectrometry.
    Qu M; An B; Shen S; Zhang M; Shen X; Duan X; Balthasar JP; Qu J
    Mass Spectrom Rev; 2017 Nov; 36(6):734-754. PubMed ID: 27097288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The flexibility of a generic LC-MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies.
    Lanshoeft C; Wolf T; Walles M; Barteau S; Picard F; Kretz O; Cianférani S; Heudi O
    J Pharm Biomed Anal; 2016 Nov; 131():214-222. PubMed ID: 27599352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. General LC-MS/MS method approach to quantify therapeutic monoclonal antibodies using a common whole antibody internal standard with application to preclinical studies.
    Li H; Ortiz R; Tran L; Hall M; Spahr C; Walker K; Laudemann J; Miller S; Salimi-Moosavi H; Lee JW
    Anal Chem; 2012 Feb; 84(3):1267-73. PubMed ID: 22243404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A whole-molecule immunocapture LC-MS approach for the in vivo quantitation of biotherapeutics.
    Kellie JF; Kehler JR; Mencken TJ; Snell RJ; Hottenstein CS
    Bioanalysis; 2016 Oct; 8(20):2103-14. PubMed ID: 27611496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.